Biohaven Ltd (BHVN)
45.35
+0.16
(+0.35%)
USD |
NYSE |
Nov 22, 15:52
Biohaven Total Liabilities (Quarterly): 194.52M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 194.52M |
| June 30, 2024 | 198.90M |
| March 31, 2024 | 117.08M |
| December 31, 2023 | 85.24M |
| September 30, 2023 | 92.73M |
| June 30, 2023 | 119.48M |
| Date | Value |
|---|---|
| March 31, 2023 | 146.26M |
| December 31, 2022 | 123.01M |
| September 30, 2022 | 35.43M |
| June 30, 2022 | 70.58M |
| December 31, 2021 | 47.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
35.43M
Minimum
Sep 2022
198.90M
Maximum
Jun 2024
111.87M
Average
117.08M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| Scholar Rock Holding Corp | 99.94M |
| Veru Inc | 27.01M |
| Regeneron Pharmaceuticals Inc | 8.116B |
| Vanda Pharmaceuticals Inc | 103.89M |
| Oramed Pharmaceuticals Inc | 9.559M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 510.52M |
| Shareholders Equity (Quarterly) | 316.01M |